International Laboratories has issued a voluntary nationwide recall of one variant of its Pravastatin Sodium tablets due to mislabelling.

Bottles that have been packaged with the Pravastatin Sodium USP 40mg label reportedly contain Bupropion Hydrochloride XL 300mg tablets.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The company announced the recall after a pharmacist informed that one 30ct bottle of Pravastatin product was mislabelled and contained Bupropion Hydrochloride XL 300mg tablets.

If a patient consumes Bupropion, an aminoketone antidepressant indicated for the treatment of major depressive disorder (MDD), the individual may exhibit various minor side effects, including nausea, vomiting, headache, constipation, sweating and blurry vision.

However, epilepsy patients and people on MAOIs are at a higher risk of possible allergic reactions that can be life-threatening.

The product was delivered to several distribution centres and retail stores in more than 20 US states.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

To date, International Laboratories received no complaints or reports of medical illnesses or harmful effects due to mislabelling.

"The product was delivered to several distribution centres and retail stores in more than 20 US states."

International Laboratories is currently asking its distributors and customers to return all recalled products.

Consumers who have purchased the product will receive a complete refund by returning the sealed package from respective stores or calling the company's complaint number.

Pravastatin Sodium Tablets USP 40mg are an HMG-CoA reductase inhibitor (statin) for patients affected by heterozygous familial hypercholesterolemia.

The company noted that the US Food and Drug Administration was informed about the labelling issue prior to the recall.

Image: Pravastatin Sodium Tablet USP 40 mg. Photo: courtesy of PR NewsFoto / International Laboratories.